← Back to headlines
Innovative Lupus Therapies Unequally Accessible in Serbia
Innovative therapies and medications for lupus are not equally accessible to all patients in Serbia, despite the possibility of reimbursement from the RFZO, due to administrative barriers and inconsistent practices in healthcare institutions.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
